4.9 C
Sunday, January 23, 2022

This drug has done great work in Corona treatment, many companies have reduced the price, Cadila has reduced the price by one-third

- Advertisement -spot_imgspot_img
- Advertisement -

Remadecivir is considered very effective medicine in the treatment of corona. On the direction of the government, all companies have cut the price of this company drastically.

Cadila has reduced the price of Remdac (Remadecivir 100 mg) injection from Rs 2,800 to Rs 899.

The National Pharmaceutical Pricing Authority (NPPA) on Saturday said that after the intervention of the government, the drug companies have reduced the price of Remedisvir Injection which is used to treat COVID-19 patients. Pharmaceutical companies Cadila Healthcare, Dr. Reddy’s Laboratories and Cipla have reduced the prices of their own brand of Remedesivir Injection (100 mg vial).

Union Chemicals and Fertilizers Minister Sadanand Gowda has expressed happiness over this step taken by the pharmaceutical companies. In a tweet, he said, “This is a great relief for the people in this critical time.” After the intervention of the government, the price of Remedisvir has come down now. I thank the companies that make the drug, they have supported Prime Minister Narendra Modi in the ongoing fight against COVID-19. Remedesivir prices have been reduced. I am thankful to the drug companies that they have supported the government in combating the COVID-19 epidemic.

The cheapest of cadilla

As per the details released by the NPPA, Cadila has reduced the price of Remdac (Remdacivir 100 mg) injection from Rs 2,800 to Rs 899. Similarly, Syngene International has reduced the price of its medicines sold under the name Remwin from Rs 3950 to Rs 2,450 per unit. Dr. Reddy’s Lab of Hyderabad sells this drug under the name Radix. He has reduced the price from Rs 5,400 to Rs 2,700 now. Similarly, Cipla’s drug Ciprimi has now become Rs 3,000. It used to be 4,000 earlier.

Mylan and Jubilant Price

Mylan has priced its brand of the drug from Rs 4,800 to Rs 3,400 and Jubilant Generics has priced its brand of the medicine at Rs 3,400 per unit. Earlier it was getting for 4,700 rupees. Similarly, Hetro Healthcare has changed the price of this medicine from Rs 5,400 to Rs 3,490. She sells it under the brand name Kovifor. In the meantime, a word of war broke out between Nationalist Congress Party (NCP) leader Nawab Malik and Union State Minister Mansukh Mandavia over the availability of Remedisvir injection in Maharashtra. In a separate tweet, Malik alleged that the central government is not allowing various export-oriented units to sell their medicines in the country. At the same time, Mandavia dismissed his allegations with strictness and said that the government is doing everything possible to double the production of the drug.

Also read, Business Ideas: Lockdown made unemployed but brilliant idea made successful entrepreneur, you also have a chance

Also read, Business Ideas: These 2 businesses can start sitting at home for just 5 thousand rupees, will earn in lakhs.

(language input)

- Advertisement -
Bhagyashree Soni
Bhagyashree Soni is a software engineer with soft writing skills. She is a degree holder from the International School of Entrepreneurial Leadership. She has been a state-level badminton champion and chess player. A woman with a forthright attitude enjoys her writing passion as her chosen career. Writing in the context of feminism, social-cause and entreprenurship is her forte.
Latest news
- Advertisement -spot_img
Related news
- Advertisement -spot_img


Please enter your comment!
Please enter your name here